CN102210768A - Traditional Chinese medicine for treating prostatic cancer - Google Patents
Traditional Chinese medicine for treating prostatic cancer Download PDFInfo
- Publication number
- CN102210768A CN102210768A CN2011101373994A CN201110137399A CN102210768A CN 102210768 A CN102210768 A CN 102210768A CN 2011101373994 A CN2011101373994 A CN 2011101373994A CN 201110137399 A CN201110137399 A CN 201110137399A CN 102210768 A CN102210768 A CN 102210768A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- treatment
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating prostatic cancer, characterized by comprising the following medicinal raw materials in proportion: 10-30 parts of astragalus root, 10-15 parts of angelica, 8-12 parts of euryale seed, 6-8 parts of antler, 10-15 parts of glossy privet fruit, 10-20 parts of gardenia fruit, 10-30 parts of honeysuckle, 10-15 parts of weeping forsythia, 6-10 parts of java brucea fruit, 8-12 parts of red peony root, 6-10 parts of hemp root, 10-15 parts of lotus root node, 10-14 parts of madder root, 8-10 parts of longhairy antenoron herb, 8-12 parts of climbing fern spore, 10-18 parts of mulberry bark and 6-10 parts of licorice. After the medicinal raw materials are selected, mixed and soaked, water is added for decocting, one dose of decoction is 200ml, 100ml of decoction is taken orally twice per day respectively in the morning and at night, and one course of treatment lasts for 10 days. The invention has the beneficial effects that the overall treatment concept for strengthening the body resistance and resisting cancer has the following therapeutic principles of: invigorating qi and nourishing the blood, strengthening the kidney and expelling toxin, dissipating blood stasis and alleviating pain, promoting blood circulation and arresting bleeding, and regulating internal secretion; diagnosis and treatment are based on an overall analysis of the illness and the condition of a patient clinically according to different syndromes; and the recurrence, spread and metastasis of cancer are effectively controlled. The medicine has quick curative effect, high remission rate and no toxic side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of carcinoma of prostate.
Background technology
Carcinoma of prostate is modal a kind of urinary system malignant tumor in the male genitourinary system tumor, mostly 50 years old with sequela, its mortality rate was directly proportional with age or transfer case.Pathogenic factor do not find out as yet, may be relevant with factors such as heredity, gonadal hormone, environment.Operative treatment is first-selected, and postoperative has certain therapeutic effect in conjunction with chemicotherapy, but the chemoradiotherapy toxic reaction is big, easily causes QI and blood deficiency, cause patient's immunity degradation, and cancer cell infiltration is very strong, easily recurrence, diffusion and transfer.
The treatment by Chinese herbs primary disease is with benefiting QI and nourishing blood; Strong kidney toxin expelling; Eliminating stasis to stop pain; The wholistic therapy theory of the right supporting anticancer of promoting blood circulation and hemostasis, endocrine regulation is the rule of treatment, often according to different pattern of syndrome determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs, controls recurrence, diffusion and the transfer of cancer effectively clinically.
Summary of the invention
The objective of the invention is provides a kind of good effect, short treating period, cure rate height in order to solve above-mentioned technical deficiency, the low and a kind of Chinese medicine for the treatment of carcinoma of prostate that has no side effect of cost.
For achieving the above object, a kind of Chinese medicine for the treatment of carcinoma of prostate is characterized in that the crude drug of Chinese medicine consists of: 10～30 parts of the Radixs Astragali, 10～15 parts of Radix Angelicae Sinensis, 8～12 parts of Semen Euryaless, 6～8 parts in Cornu Cervi Pantotrichum, 10～15 parts of Fructus Ligustri Lucidi, 10～20 parts of Fructus Gardeniaes, 10～30 parts of Flos Loniceraes, 10～15 parts of Fructus Forsythiaes, 6～10 parts of Fructus Bruceaes, 8～12 parts of Radix Paeoniae Rubra, 6～10 parts of Radix Cannabiss, 10～15 parts of Nodus Nelumbinis Rhizomatis, 10～14 parts of Radix Rubiae, 8～10 parts of Herba Lysimachiaes, 8～12 parts of Spora Lygodii, 10～18 parts of Cortex Mori, 6～10 parts in Radix Glycyrrhizae.
Chinese medicine preparation of the present invention is simple, cost is low, the medicine source is wide, easy to use, curative effect is fast, and the remission rate height is without any side effects.
Radix Astragali nature and flavor are sweet in this medicine, tepor; Return lung, spleen, liver, kidney channel.Effect: benefiting QI for strengthening the superficies, arresting sweating take off admittedly, granulation promoting, inducing diuresis to remove edema.Contain various trace elements, mend all empty deficiencies, have the function of enhancing body reticular system, antitumaous effect.Radix Angelicae Sinensis nature and flavor temperature, ignorant sweet, hot; Return liver, the heart, spleen channel.Has the promoting blood circulation and stopping pain of enriching blood, effect of relaxing bowel.Contain basic lactone, nicotinic acid, sucrose and several amino acids etc., be used for the patient of had repeated hematuria, blood deficiency and yellow complexion, dizzy cardiopalmus.Semen Euryales sweet-puckery flavor, flat is gone into spleen, kidney channel.Has supplementing the kidney to control the nocturnal, spleen reinforcing antidiarrheal, the function of damp eliminating leukorrhagia stopping.Cornu Cervi Pantotrichum sweet-salty, temperature.Effect: mend marrow, help kidney yang, strengthening the tendons and bones has the effect of phytoestrogen sample, and modern medicine study is isolated estradiol, estrone etc. from the fat-soluble composition of Cornu Cervi Pantotrichum, and is rich in 16 seed amino acids.Fructus Ligustri Lucidi sweet in the mouth, hardship, cool in nature, effect: liver and kidney tonifying; Clearind deficient heat.Multiple pharmacologically actives such as the effect of phytoestrogen sample, immunological enhancement.Fructus Gardeniae nature and flavor hardship, cold; GUIXIN, liver, lung, stomach warp, tri-jiao channel.Effect: clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, reducing swelling and alleviating pain.Flos Lonicerae nature and flavor sweet in the mouth, cold is returned lung; Heat-clearing and toxic substances removing." book on Chinese herbal medicine is just ": Flos Lonicerae, be good at removing toxic substances, really be key medicine.Poison not Cheng Zheneng looses, and poison Cheng Zheneng is burst, and Fructus Forsythiae nature and flavor hardship, is slightly cold.Go into the heart, lung, small intestine meridian.Effect: heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.The Fructus Bruceae nature and flavor: hardship, cold.Effect: removing pathogenic heat from blood and toxic substance from the body, be apt to control hot bloody dysentery, two just because of hot hematochezia.Radix Paeoniae Rubra: bitter in the mouth, cold nature.Return Liver Channel.Effect: the function with clearing away heat and cooling blood, eliminating stasis to stop pain can strengthen the phagocytic function of reticuloendothelial system and strengthen OA, with the protection hepatocyte, prevents the liver immunologic injury and promotes liver cell regeneration.The Radix Cannabis bitter in the mouth; Property is put down, effect: blood stasis dispelling, hemostasis, diuresis.The Nodus Nelumbinis Rhizomatis sweet-puckery flavor, flat, few the moon of starting with, bright, the JUE YIN meridian of foot sun.Effect: hemostasis, dissipating blood stasis. " not record ": main heat is thirsty, diffusing blood, granulation promoting.Radix Rubiae nature and flavor hardship, cold is gone into spleen, stomach two warps.Effect: promoting the circulation of blood hemostasis, dredge the meridian passage.Herba Lysimachiae sweet in the mouth, little hardship, cool in nature.Return liver, gallbladder, kidney, urinary bladder channel.Effect: relieving stranguria by diuresis; Heat-clearing and toxic substances removing; Dissipating blood stasis for subsidence of swelling.Cold in nature, the sweet in the mouth of Spora Lygodii is returned bladder, small intestine meridian.The Cortex Mori sweet in the mouth is cold, goes into lung meridian, effect: tonify deficiency QI invigorating, detumescence, diuretic.Radix Glycyrrhizae property is flat, sweet in the mouth, returns 12 warps.Effect: invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
Manufacture method of the present invention is, above all crude drug chosen, mixed add decocting after the immersion and become every dose of 200ml of decoction, and every day is early, evening 2 times is for oral administration, each 100ml, and 10 days was 1 course of treatment.
The present invention is through clinical verification, and effective percentage is more than 95%, and total remission rate is 75.2%.
The specific embodiment
Below in conjunction with implementing case the present invention is further described:
Implement 1: a kind of Chinese medicine for the treatment of carcinoma of prostate is characterized in that by following proportioning weighting raw materials thing: 10～30 parts of the Radixs Astragali, 10～15 parts of Radix Angelicae Sinensis, 8～12 parts of Semen Euryaless, 6～8 parts in Cornu Cervi Pantotrichum, 10～15 parts of Fructus Ligustri Lucidi, 10～20 parts of Fructus Gardeniaes, 10～30 parts of Flos Loniceraes, 10～15 parts of Fructus Forsythiaes, 6～10 parts of Fructus Bruceaes, 8～12 parts of Radix Paeoniae Rubra, 6～10 parts of Radix Cannabiss, 10～15 parts of Nodus Nelumbinis Rhizomatis, 10～14 parts of Radix Rubiae, 8～10 parts of Herba Lysimachiaes, 8～12 parts of Spora Lygodii, 10～18 parts of Cortex Mori, 6～10 parts in Radix Glycyrrhizae.Above all crude drug are chosen, mix add decocting after the immersion and become every dose of 200ml of decoction, every day early, evening 2 times is for oral administration, each 100ml.Effective percentage is more than 95%, and remission rate is 77.6%.
Implement 2: a kind of Chinese medicine for the treatment of carcinoma of prostate, its preferred side is: 15 parts of the Radixs Astragali, 12 parts of Radix Angelicae Sinensis, 10 parts of Semen Euryaless, 8 parts in Cornu Cervi Pantotrichum, 10 parts of Fructus Ligustri Lucidi, 15 parts of Fructus Gardeniaes, 15 parts of Flos Loniceraes, 12 parts of Fructus Forsythiaes, 8 parts of Fructus Bruceaes, 10 parts of Radix Paeoniae Rubra, 8 parts of Radix Cannabiss, 12 parts of Nodus Nelumbinis Rhizomatis, 10 parts of Radix Rubiae, 8 parts of Herba Lysimachiaes, 10 parts of Spora Lygodii, 12 parts of Cortex Mori, 8 parts in Radix Glycyrrhizae.Above all crude drug are chosen, mix add decocting after the immersion and become every dose of 200ml of decoction, each 100ml, every day is early, evening 2 times is for oral administration, and the person Fructus Gardeniae reduces by half should to note the weakness of the spleen and stomach when taking we.
Clinical efficacy is summed up:
One, physical data: the patient who select the carcinoma of prostate postoperative, put, chemotherapy is crossed, totally 62 examples, age 45-68 year, average 53 years old, in the course of disease 10 months, average 5-7 month, the patient made a definite diagnosis through hospital above county level and implements above-mentioned treatment.
Two, diagnostic criteria: early stage non-evident sympton along with the development of the state of an illness, can have frequent micturition, urgent micturition, urine rheology thin, hematuria, the pain etc. of urinating.Carcinoma of prostate is often soaked into near tissue or adjacent organs, or capable of metastasis through lymph, blood.Invade and ejaculatory duct can cause that hemospermia and semen volume reduce and sexual impotence as tumor.Auxiliary examination: digital rectal examination (DRE), blood-serum P SA concentration determination or rectum B ultrasonic needle puncture biopsy are made a definite diagnosis.
Three, curative effect judging standard (short term effect):
Alleviation is meant the symptom complete obiteration fully, continues for 4 weeks at least, does not have new focus therebetween and occurs.
Part alleviate be meant with treat before compare all the perpendicular diameter products that can survey focus summation reduce and surpass 50%, continued for 4 weeks at least, do not have the appearance of new focus during this period.
Invalid: symptom does not have to improve or have has new focus to occur therebetween
Four, method of administration: be decocted in water for oral dose, every day 1 dose, every dose 200ml, sub-service sooner or later, 10 days was 1 course of treatment, drug withdrawal is 2 days between two courses of treatment.
Five, therapeutic effect: short term effect: total remission rate 75.2%; Clinical disease: significantly improve 32 people, partly improve 33 people, do not have 3 people of improvement.Quality of life changes relatively: improve 42 examples, stablize 19 examples, 3 examples that descend, obvious effective rate 95.3%, inefficiency 4.68%.
Six, model case
1, chaste tree XX, the man, 58 years old, in JIUYUE, 2009 carcinoma of prostate postoperative was 4 months,, 1 week of painless hematuria appears again, and companion's irritation sign of bladder was gone to a doctor in 1 day, and the urine exfoliative cytology is checked positive, and rectum B ultrasonic needle puncture biopsy is made a definite diagnosis., promptly obey totally 30 doses of 3 courses of treatment of this Chinese medicine, 1 dose of every day, 10 days was 1 course of treatment, obey 10 doses after no hematuria the Radix Cirsii Japonici of stopping using appears.So far not recurrence.
2, Song XX, the man, 62 years old, went to a doctor in November, 2009.Postoperative half a year, chemotherapy 6 cycles of one course of treatment.Intermittent gross hematuria 3 days occur, irritations sign of bladder such as companion frequent micturition, urgent micturition, dysurea 1 day are through 20 doses of 2 courses of treatment of clothes Chinese medicine of the present invention, remission.Drug withdrawal 1 month continues to obey for 1 course of treatment, so far recurrence.
3, Deng XX, the man, 49 years old, went to a doctor in April, 2010.The patient is by diagnosing prostate cancer 3 months, row excision 3 months, and in 3 cycles of chemotherapy, it is thin that frequent micturition, urgent micturition, urine rheology appear in the patient, hematuria, the pain of urinating, blood-serum P SA concentration determination and rectum B ultrasonic needle puncture biopsy are made a definite diagnosis recurrence.The patient requires to obey 1 week of drug withdrawal after 20 doses of 2 courses of treatment of Chinese medicine of the present invention, obeys 20 doses of 2 courses of treatment again, so far recurrence.
Claims (2)
1. Chinese medicine for the treatment of carcinoma of prostate: it is characterized in that it is a medicine by following proportioning: 10～30 parts of the Radixs Astragali, 10～15 parts of Radix Angelicae Sinensis, 8～12 parts of Semen Euryaless, 6～8 parts in Cornu Cervi Pantotrichum, 10～15 parts of Fructus Ligustri Lucidi, 10～20 parts of Fructus Gardeniaes, 10～30 parts of Flos Loniceraes, 10～15 parts of Fructus Forsythiaes, 6～10 parts of Fructus Bruceaes, 8～12 parts of Radix Paeoniae Rubra, 6～10 parts of Radix Cannabiss, 10～15 parts of Nodus Nelumbinis Rhizomatis, 10～14 parts of Radix Rubiae, 8～10 parts of Herba Lysimachiaes, 8～12 parts of Spora Lygodii, 10～18 parts of Cortex Mori, 6～10 parts in Radix Glycyrrhizae.
2. a kind of Chinese medicine for the treatment of carcinoma of prostate according to claim 1, its preferred side is: 15 parts of the Radixs Astragali, 12 parts of Radix Angelicae Sinensis, 10 parts of Semen Euryaless, 8 parts in Cornu Cervi Pantotrichum, 10 parts of Fructus Ligustri Lucidi, 15 parts of Fructus Gardeniaes, 15 parts of Flos Loniceraes, 12 parts of Fructus Forsythiaes, 8 parts of Fructus Bruceaes, 10 parts of Radix Paeoniae Rubra, 8 parts of Radix Cannabiss, 12 parts of Nodus Nelumbinis Rhizomatis, 10 parts of Radix Rubiae, 8 parts of Herba Lysimachiaes, 10 parts of Spora Lygodii, 12 parts of Cortex Mori, 8 parts in Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101373994A CN102210768A (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating prostatic cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101373994A CN102210768A (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating prostatic cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102210768A true CN102210768A (en) | 2011-10-12 |
Family
ID=44742452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101373994A Pending CN102210768A (en) | 2011-05-15 | 2011-05-15 | Traditional Chinese medicine for treating prostatic cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102210768A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709154A (en) * | 2016-04-25 | 2016-06-29 | 范士怀 | Traditional Chinese medicine preparation for treating prostate tumor |
| CN106344830A (en) * | 2016-10-10 | 2017-01-25 | 南宁多灵生物科技有限公司 | Traditional Chinese medicine composition for treating prostatic cancer |
| CN112437660A (en) * | 2018-06-01 | 2021-03-02 | 耶鲁大学 | Compositions and methods for treating steroid hormone related diseases or disorders |
-
2011
- 2011-05-15 CN CN2011101373994A patent/CN102210768A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709154A (en) * | 2016-04-25 | 2016-06-29 | 范士怀 | Traditional Chinese medicine preparation for treating prostate tumor |
| CN106344830A (en) * | 2016-10-10 | 2017-01-25 | 南宁多灵生物科技有限公司 | Traditional Chinese medicine composition for treating prostatic cancer |
| CN112437660A (en) * | 2018-06-01 | 2021-03-02 | 耶鲁大学 | Compositions and methods for treating steroid hormone related diseases or disorders |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705897B (en) | A kind of cancer relieves the pain plaster | |
| CN101502634B (en) | Chinese medicinal composition for treating uterine blood flow and preparation method thereof | |
| CN101874867B (en) | Chinese medicinal preparation for treating psoriasis | |
| CN101934052B (en) | Medicament for treating facial chloasma and preparation method thereof | |
| CN103055130A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN102688420A (en) | Traditional Chinese medicine decoction for treating psoriasis | |
| CN103479929A (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN101912551B (en) | Miscarriage-prevention Chinese medicinal composition | |
| CN102210768A (en) | Traditional Chinese medicine for treating prostatic cancer | |
| CN104740583A (en) | Traditional Chinese medicine preparation for relieving Crohn's disease and preparation method for traditional Chinese medicine preparation | |
| CN111840419A (en) | Intelligent system preparation for conditioning physique and preventing and treating various skin diseases and preparation method | |
| CN101670044A (en) | Medicine for curing gestational chloasma and preparation method thereof | |
| CN102988781A (en) | Traditional Chinese medicine liniment for inhibiting cancer and relieving pain | |
| CN101057922B (en) | Traditional Chinese medicine preparation for treating vitiligo | |
| CN105456428A (en) | Traditional Chinese medicine formula for inhibiting regrowth of tumor cells and preparation method thereof | |
| CN104758845A (en) | External traditional Chinese medicine ointment for treating scapulohumeral periarthritis | |
| CN105012735A (en) | Traditional Chinese medicine composition for tonifying qi and blood and resisting cancer | |
| CN104800389A (en) | External use liquid medicine for treating eczema | |
| CN101658616B (en) | Chinese medicinal composition for treating psoriasis | |
| CN103212037A (en) | Traditional Chinese medicine for treating female endocrine disorder and preparation method of traditional Chinese medicine | |
| CN103990058A (en) | Menstruation promoting and vigor keeping paste | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN101658652A (en) | Chinese medicinal preparation for treating chronic appendicitis | |
| CN104740557A (en) | Traditional Chinese medicine composition and cream for treating rheumatism and preparation method of traditional Chinese medicine composition and cream | |
| CN104666645A (en) | Formula of traditional Chinese medicine for treating freckles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111012 |